EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes of Neonates Receiving Antihypertensive Treatment

Zehra Aydin, Elvis Kraja, Samet Benli, Emine Ozlem Cam Delebe, Nevin Ozdemiroğlu, Munevver Tugba Temel

Zeitschrift für Geburtshilfe und Neonatologie · 01.06.2026 · 230 (03) · 232-236

DOI: 10.1055/a-2814-4099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Geburtshilfe und Neonatologie, erschienen am 01.06.2026. Verfasst von Zehra Aydin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology, Ministry of Health Gaziantep City Hospital, Gaziantep, Turkey. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Neonatal hypertension is uncommon but clinically significant due to its systemic complications. Data on the clinical course, etiologies, and outcomes of neonates receiving antihypertensive therapy in the neonatal intensive care unit are limited. This study aimed to describe the clinical characteristics, underlying etiologies, management strategies, and outcomes of neonates receiving antihypertensive therapy in a tertiary level 4 NICU.

Methods

We conducted a retrospective review of medical records of neonates admitted to the NICU between January 2024 and June 2025 who received antihypertensive treatment. Etiologies were classified as renal, vascular, or miscellaneous. Follow-up data were analyzed to identify persistence of hypertension after discharge.

Results

Of 17 neonates, 9 (52%) were preterm and 8 (47%) were term. Renal etiologies predominated (47%), including acute kidney injury, congenital anomalies of the kidney and urinary tract, and polycystic kidney disease. Vascular causes accounted for 5.8%, and miscellaneous etiologies, such as intracranial lesions and sepsis, for 47%. Monotherapy with amlodipine, enalapril, or captopril was used in most cases, while combination therapy was required in two neonates with renal etiologies. Four neonates (23.5%) were discharged on ongoing antihypertensive therapy, all with structural or genetic renal or vascular abnormalities.

Conclusions

Neonatal hypertension is heterogeneous, with renal disorders being the most frequent cause. Persistent hypertension occurs mainly in neonates with structural renal or vascular abnormalities, while those with other causes often discontinue therapy before discharge. These findings highlight the importance of identifying neonates at risk for long-term complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionHumansInfant, NewbornFemaleMaleTreatment OutcomeRetrospective StudiesIntensive Care Units, Neonatal

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Pediatric Nephrology, Ministry of Health Gaziantep City Hospital, Gaziantep, Turkey.
  • Department of Neonatology, Ministry of Health Gaziantep City Hospital, Gaziantep, Turkey.
  • Department of Pediatric Cardiology, Ministry of Health Gaziantep City Hospital, Gaziantep, Turkey.

Zitieren

APA

Aydin, Z., Kraja, E., Benli, S., Cam Delebe, E. O., Ozdemiroğlu, N., & Temel, M. T. (2026). Clinical Outcomes of Neonates Receiving Antihypertensive Treatment. Zeitschrift für Geburtshilfe und Neonatologie, 230(03), 232-236. https://doi.org/10.1055/a-2814-4099

Vancouver

Aydin Z, Kraja E, Benli S, Cam Delebe EO, Ozdemiroğlu N, Temel MT. Clinical Outcomes of Neonates Receiving Antihypertensive Treatment. Zeitschrift für Geburtshilfe und Neonatologie. 2026;230(03):232-236. doi:10.1055/a-2814-4099

BibTeX
@article{Aydin2026,
  author = {Aydin, Zehra and Kraja, Elvis and Benli, Samet and Cam Delebe, Emine Ozlem and Ozdemiroğlu, Nevin and Temel, Munevver Tugba},
  title = {Clinical Outcomes of Neonates Receiving Antihypertensive Treatment},
  journal = {Zeitschrift für Geburtshilfe und Neonatologie},
  year = {2026},
  volume = {230},
  number = {03},
  pages = {232--236},
  doi = {10.1055/a-2814-4099}
}
Kostenlos starten →